Neuromuscular Physiology


IV.  The neuromuscular junction (NMJ) or the endplate is a highly specialized synapse at which presynaptic motor nerve endings meet the postsynaptic membranes of skeletal muscles (motor endplates) (Fig. 11-2). The NMJ is designed to transmit electrical impulses from the nerve terminal to the skeletal muscle via the chemical transmitter, acetylcholine (ACh). Structurally, the NMJ is consisted of a three components: (a) the presynaptic (or prejunctional) nerve terminal containing synaptic vesicles (filled with ACh) and mitochondria; (b) the synaptic cleft that contains basal lamina to which acetylcholinesterase enzyme responsible for hydrolysis of free ACh is attached; and (c) the postsynaptic (or postjunctional) muscle membrane that opposes the nerve terminal.



A.  Presynaptic Region


  1.  Synaptic vesicles are specialized secretory organelles (see Fig. 11-2). Each vesicle appears to contain 5,000 to 10,000 molecules of acetylcholine. Nearly 50% of the released acetylcholine is rapidly hydrolyzed by the acetylcholinesterase during the time of diffusion across the synaptic cleft.


B.  Synaptic cleft separates nerve and muscle fiber plasma membranes (Fig. 11-3). Acetylcholinesterase ranks as one of the highest catalytic efficiencies known (4,000 molecules of acetylcholine hydrolyzed per active site per second) at near diffusion-limited rates.



C.  The Nicotinic Acetylcholine Receptor at the Neuromuscular Junction (Fig. 11-4).



  1.  Nondepolarizing neuromuscular blocking drugs bind to one or both α subunits, but unlike acetylcholine, lack agonist activity (competitive blockade).


a.  As a result, conformational changes do not occur, and the receptor channel remains closed.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 14, 2016 | Posted by in PHARMACY | Comments Off on Neuromuscular Physiology

Full access? Get Clinical Tree

Get Clinical Tree app for offline access